drugset / Trial / NCT02624999
Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
RandomizedParallel-groupOpen-labelTreatment
Summary
Phase II, Randomized, Non-Inferiority Study Comparing an Individualized Cancer Vaccine (AlloVax™) to Chemotherapy in Subjects with R/M SCCHN .
Timeline
- Start
- 2016-12
- Primary completion
- 2016-12
- Completion
- 2017-05
Outcome
Outcome not reported
Stopped: “PI changed institution”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AlloVax | Vaccine | — | — |
| Comparator | Cisplatin | Other / unclassified | 80 mg/m2 | Intravenous |
| Comparator | Cisplatin | Other / unclassified | 100 mg/m2 | Intravenous |
| Comparator | fluorouracil | Small molecule | 1000 mg/m2 | Intravenous |